This occurs through the downregulation of DNA methyltransferases DNMT1, DNMT3A, and DNMT3B, and the upregulation of Methyl CpG Binding Domain Protein 2 (MBD2), a marker often associated with cancer due to its role in causing genomic instability and increasing mutation frequencies [22]. The gene discussed is DNMT3B; the disease is cancer.